Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quick Comparison Overview

Full Name Body Protection Compound-157 Thymosin Beta-4 Fragment Amino Acid Length 15 amino acids 43 amino acids Primary Mechanism Angiogenesis, VEGF pathway Actin regulation, cell migration Best Known For Gut healing, tendon repair, systemic protection Muscle

This comparison does not assign a generated winner or score.

  • Full Name
  • Body Protection Compound-157
  • Thymosin Beta-4 Fragment
  • Amino Acid Length
  • 15 amino acids
  • 43 amino acids
  • Primary Mechanism
  • Angiogenesis, VEGF pathway
  • Actin regulation, cell migration
  • Best Known For
  • Gut healing, tendon repair, systemic protection
  • Muscle injury, inflammation reduction, systemic healing
  • Research Dosage Range
  • 200-500 mcg per administration
  • 2-5 mg per administration
  • Administration Route
  • Subcutaneous, intramuscular, oral
  • Subcutaneous, intramuscular
  • Half-Life
  • ~4 hours (stable)
  • ~2.5 hours
  • Oral Bioavailability
  • Yes (unique advantage)
  • No
  • Typical Research Duration
  • 4-8 weeks
  • 4-6 weeks
  • Cost per Protocol
  • Lower (smaller doses needed)
  • Higher (larger doses needed)
More references

Related material

Comparison

BPC-157 vs TB-500

BPC-157 vs TB-500 A 2026 UK research comparison of BPC-157 and TB-500 — two distinct peptides with overlapping preclinical evidence in tendon, ligament and muscle repair. Mechanis…

View details →
Comparison

BPC-157 vs TB-500

Last updated: April 2026 · UK research-grade reference · For laboratory research use only — not for human consumption

View details →
Comparison

3. Mechanism comparison

BPC-157 mechanism (primary axes): VEGFR2 activation → angiogenesis FAK-paxillin pathway → fibroblast migration Nitric oxide system modulation EGR1 pathway engagement Protection ag…

View details →